• -
196 Results
Marijuana Law
Latin America Initiative | Commentary
Marijuana Decriminalization in the Caribbean
Governments of the Caribbean Community and Common Market (CARICOM) have called for a discussion on the decriminalization of marijuana after a pilot study found that legalized medical marijuana sales could boost the region’s ailing economies. As a result, the topic was an important agenda item at a CARICOM Inter-Sessional Heads of State Summit held in March 2014. Two aspects of decriminalization were discussed: decriminalization for medical use and decriminalization for recreational use.
August 15, 2014
Microscope
The Federal Research Portfolio: Capitalizing on Investments in R&D
Neal Lane, senior fellow in science and technology policy, testified before the Senate Committee on Commerce, Science and Transportation on July 17, 2014. Lane is co-chair of the American Academy of Arts and Science's project on New Models for U.S. Science and Technology Policy, and his testimony addressed the project's objective of sustaining a long-term, nonpartisan, national focus on science and technology policy issues of vital importance to the country.
Neal F. Lane July 17, 2014
A gavel rests in front of the Mexican flag.
Vigilantism in Mexico: A New Phase in Mexico's Security Crisis
The violent struggle between rival Mexican drug cartels and other criminal groups has left tens of thousands dead and towns across Mexico paralyzed with fear. With overwhelmed police forces relatively powerless to control drug-related murders and kidnappings, a growing number of vigilante organizations, or self-defense groups, aim to restore order — but now even they are fighting, and killing, among themselves.
Gary J. Hale April 18, 2014
Vaccine
Chemotherapy Drug Shortages in the U.S. — The Recurring Nightmare
Cancer drug shortages are almost uniquely associated with generic drugs (small profit margins) and rarely with patented drugs (large profit margins). They are common in the U.S., but uncommon in Europe and elsewhere, where generic drug prices are on average higher than in the U.S. This suggests the main cause of drug shortages is economic.
Hagop M. Kantarjian, Vivian Ho March 13, 2014